Nutex Health Inc.
NUTX
$176.53
$0.060.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 598.79% | -175.95% | -76.25% | 801.02% | -2,314.56% |
| Total Depreciation and Amortization | -4.67% | 3.06% | -3.57% | 6.20% | 9.68% |
| Total Amortization of Deferred Charges | 0.40% | -0.79% | 6.35% | 5.27% | 5.61% |
| Total Other Non-Cash Items | -19.05% | 61.07% | 52.15% | 266.08% | 121.09% |
| Change in Net Operating Assets | 36.77% | -113.99% | 70.35% | -11,154.45% | -125.76% |
| Cash from Operations | 265.10% | -46.52% | 95,161.68% | -99.21% | -48.81% |
| Capital Expenditure | 89.00% | -4,189.06% | 83.81% | 35.95% | -10.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -100.00% | 149.23% |
| Other Investing Activities | -100.00% | -- | -- | -- | -- |
| Cash from Investing | -254.08% | 406.25% | 98.08% | -1,149.44% | 78.98% |
| Total Debt Issued | -46.38% | -79.04% | 255.97% | -63.56% | 45.40% |
| Total Debt Repaid | -37.15% | -47.65% | 34.56% | -66.50% | -42.14% |
| Issuance of Common Stock | -69.42% | -- | -- | 171.53% | 385.05% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -24.62% | -- | -- | -54.63% | 3.49% |
| Cash from Financing | -93.52% | -126.79% | -128.12% | -609.29% | 64.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 477.43% | -72.77% | 803.32% | -202.77% | -43.53% |